Treatment Overview
Diquafosol Sodium Ophthalmic Solution Therapy in Korea is an advanced, pharmacological treatment developed to enhance natural tear secretion and improve the overall quality of the tear film in patients with Dry Eye Syndrome. Unlike artificial tears that only provide temporary moisture, diquafosol sodium acts at the cellular level to stimulate mucin and aqueous secretion from the conjunctival and corneal epithelial cells, promoting natural and sustained ocular hydration.
Korean ophthalmologists integrate AI-guided tear film diagnostics, customized dosing protocols, and precision ocular imaging to tailor this therapy to each patient’s unique tear deficiency type. The treatment addresses both evaporative and aqueous-deficient dry eye, improving lubrication, corneal surface health, and visual clarity.
Diquafosol Sodium Ophthalmic Solution Therapy in Korea provides a scientifically proven, safe, and long-term approach to restoring natural tear balance and comfort.
Purpose & Benefits
Purpose
- Stimulate natural tear production and mucin secretion from ocular surface cells.
- Rehydrate and stabilize the tear film for long-term comfort.
- Reduce inflammation and dryness-related irritation.
- Repair microdamage to corneal epithelial cells.
- Improve vision clarity and ocular comfort.
Benefits
- Physiological Tear Enhancement: Encourages natural tear secretion rather than artificial replacement.
- Dual-Action Therapy: Stimulates both mucin and aqueous components for balanced hydration.
- Long-Term Relief: Sustained improvement in tear stability and comfort.
- Safe & Non-Invasive: Suitable for chronic or post-surgical dry eye management.
- Improved Visual Clarity: Maintains a smooth refractive surface for sharper vision.
- Compatible with Other Therapies: Can be combined with LipiFlow, serum drops, or regenerative care.
Ideal Candidates
Diquafosol Sodium Ophthalmic Solution Therapy in Korea is ideal for:
- Patients with mild to severe Dry Eye Syndrome.
- Individuals with aqueous or mucin-deficient dry eye.
- Post-LASIK, PRK, or cataract patients experiencing chronic dryness.
- Those with Meibomian gland dysfunction or ocular surface inflammation.
- Individuals seeking a pharmacologic solution that restores natural tear physiology.
Possible Risks & Complications
Diquafosol sodium is clinically proven and well-tolerated, with minimal side effects. Mild, temporary effects may include:
- Mild Stinging or Blurriness: Short-lived after application.
- Watery Eyes: As natural tear secretion increases.
- Transient Redness: Resolves quickly with continued use.
Korean ophthalmologists monitor each patient’s progress using AI-based tear film analysis and ocular surface imaging to ensure maximum safety and effectiveness.
Techniques & Technology Used
Core Techniques
- AI-Guided Tear Film Diagnostics: Evaluates tear breakup time, stability, and gland function.
- Precision Prescription Planning: Customizes dosing frequency and concentration per individual.
- High-Purity Diquafosol Formulations: Ensures maximum cellular response and biocompatibility.
- Ocular Surface Regeneration Support: Enhances epithelial healing and tear layer adhesion.
- Digital Tear Film Monitoring: Tracks therapeutic response and hydration over time.
- Combination Therapy Integration: Can be used alongside anti-inflammatory or regenerative eye care.
These methods make Diquafosol Sodium Ophthalmic Solution Therapy in Korea a cornerstone in modern pharmacologic dry eye management.
Treatment Process in Korea
Step-by-Step Workflow
Step 1 – Diagnostic Evaluation:
Comprehensive tear film and corneal imaging identify tear deficiency type and severity.
Step 2 – Personalized Prescription:
Diquafosol sodium drops are prescribed with a customized dosage plan.
Step 3 – Application Phase:
The drops are applied multiple times per day (typically 6 times daily) to stimulate tear and mucin production.
Step 4 – Monitoring & Adjustment:
Progress is assessed through follow-up imaging to fine-tune dosage and evaluate healing.
Step 5 – Maintenance Therapy:
Long-term use helps maintain hydration and protect the ocular surface.
Treatment Duration: Continuous daily use for 4–12 weeks initially; ongoing maintenance as recommended.
Recovery & After-Care
After-Care Guidelines
- Apply drops at regular intervals as prescribed by the ophthalmologist.
- Store eye drops properly to maintain sterility and efficacy.
- Avoid touching the applicator tip to the eye surface.
- Combine with lubricating or regenerative therapy if advised.
- Attend follow-up appointments for ocular surface assessment.
Recovery Timeline
- Week 1: Noticeable increase in moisture and tear film stability.
- Weeks 2–4: Reduction in dryness and irritation; improved corneal surface quality.
- 1–3 Months: Full tear film restoration and sustained comfort achieved.
- Beyond 3 Months: Ongoing protection and improved ocular health with maintenance use.
Results & Longevity
Expected Results
- Increased natural tear and mucin production.
- Reduction in dryness, irritation, and redness.
- Enhanced vision clarity and optical stability.
- Long-lasting ocular surface protection.
Longevity
Diquafosol Sodium Ophthalmic Solution Therapy offers sustained improvement in ocular hydration and tear quality with consistent use.
Korean clinics report over 90% patient satisfaction, with significant improvement in tear stability and ocular comfort lasting for months.
Why Korea Is a Top Destination
Korea is at the forefront of ocular pharmacotherapy and regenerative ophthalmology, offering advanced diagnostic systems and precision-based treatment protocols for chronic dry eye.
- AI-Calibrated Diagnostic Imaging: Ensures accurate evaluation and tailored therapy.
- Advanced Pharmaceutical Integration: Uses high-grade, clinically approved diquafosol formulations.
- Expert Ophthalmologists: Specialized in tear film biology and ocular surface restoration.
- Personalized Treatment Plans: Adjusted based on individual tear film response.
- Comprehensive Eye Care Systems: Combine medication, diagnostics, and regenerative therapy.
- Proven Clinical Outcomes: Consistent, long-lasting relief for chronic dryness.
Unique Korean Methods & Technology
- AI-Guided Tear Film & Mucin Layer Analysis
- High-Purity Pharmaceutical Diquafosol Formulations
- Customized Dosage and Administration Protocols
- Ocular Surface Regeneration Integration
- Long-Term Hydration & Tear Film Stability Monitoring
- Comprehensive Dry Eye Rehabilitation Programs
These innovations make Diquafosol Sodium Ophthalmic Solution Therapy in Korea one of the most effective, science-based, and reliable treatments for restoring natural tear function and relieving chronic Dry Eye Syndrome.
Cost Range
| Treatment Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Standard Diquafosol Therapy | ₩300,000 – ₩600,000 | ~$215 – $430 | Basic prescription and initial diagnostic evaluation |
| AI-Guided Customized Program | ₩700,000 – ₩1,200,000 | ~$500 – $850 | Personalized dosing plan with tear film imaging |
| Premium Regenerative Dry Eye Program | ₩1,500,000 – ₩2,500,000+ | ~$1,100 – $1,800+ | Diquafosol therapy combined with biologic or regenerative eye care |
Pricing may vary depending on the formulation, treatment duration, and clinical technology used.
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul): Expert in AI-guided diquafosol therapy and advanced dry eye management.
- Dream Eye Center (Seoul): Specialized in tear film enhancement and mucin restoration therapies.
- BGN Eye Clinic (Busan & Seoul): Offers comprehensive diquafosol programs with regenerative eye care.
- Glory Seoul Eye Clinic: Renowned for chronic dry eye treatment and ocular surface repair.
- K-Cure Vision Center (Gangnam): Pioneers in customized diquafosol sodium therapy and AI-driven ocular diagnostics.
